Department of Cardiology and Department of Health, Medicine and Caring Sciences, Linkoping University, Linkoping, Sweden.
Division of cardiology, Department of Medicine, Karolinska Institute, Stockholm, Sweden.
BMJ Open. 2022 Jun 1;12(6):e060949. doi: 10.1136/bmjopen-2022-060949.
The aim of this study was to conduct a nationwide all comer description of incidence, contemporary management and outcome in Swedish spontaneous coronary artery dissection (SCAD) patients. The incidence of SCAD as well as the management and outcome of these patients is not well described.
A nationwide observational study.
All patients with SCAD registered in the Swedish Coronary Angiography and Angioplasty Register from 2015 to 2017 were included. The index angiographies of patients with registered SCAD were re-evaluated at each centre to confirm the diagnosis. Patients with non-SCAD myocardial infarction (MI) (n=32 601) were used for comparison.
Outcomes included all-cause mortality, reinfarction or acute coronary reangiography.
This study found 147 SCAD patients, rendering an incidence of 0.74 per 100 000 per year and a prevalence of 0.43% of all MIs. The average age was 52.9 years, 75.5% were women and 47.6% presented with ST-segment elevation MI. Median follow-up time for major adverse cardiac event was 17.3 months. Percutaneous coronary intervention was attempted in 40.1% of SCAD patients and 30.6% received stent. The use of antithrombotic agents was similar between the groups and there was no difference regarding outcomes, 10.9% vs 13.4%, p=0.75. Mortality was lower in SCAD patients, 2.7% vs 8.0%, p=0.03, whereas SCAD patients more often underwent acute reangiography, 9.5% vs 4.6%, p<0.01.
In this nationwide, all comer Swedish study, the overall incidence of SCAD was low, including 25% men which is more and in contrast to previous studies. Compared with non-SCAD MI, SCAD patients were younger, with lower cardiovascular risk burden, yet suffered substantial mortality and morbidity and more frequently underwent acute coronary reangiography.
本研究旨在对瑞典自发性冠状动脉夹层(SCAD)患者的发病率、现代治疗方法和结局进行全国范围内的全面描述。SCAD 的发病率以及这些患者的治疗方法和结局尚不清楚。
全国性观察性研究。
纳入 2015 年至 2017 年期间在瑞典冠状动脉造影和血管成形术登记处登记的所有 SCAD 患者。在每个中心对有登记 SCAD 的患者的索引血管造影进行重新评估以确认诊断。将 32601 例非 SCAD 心肌梗死(MI)患者用作对照。
结局包括全因死亡率、再梗死或急性冠状动脉再血管化。
本研究共发现 147 例 SCAD 患者,发病率为每年每 10 万人 0.74 例,所有 MI 的患病率为 0.43%。平均年龄为 52.9 岁,75.5%为女性,47.6%表现为 ST 段抬高型心肌梗死。主要不良心脏事件的中位随访时间为 17.3 个月。40.1%的 SCAD 患者尝试经皮冠状动脉介入治疗,30.6%的患者接受支架治疗。两组的抗血栓药物使用情况相似,结局无差异,分别为 10.9%和 13.4%,p=0.75。SCAD 患者的死亡率较低,分别为 2.7%和 8.0%,p=0.03,而 SCAD 患者更常进行急性再血管化,分别为 9.5%和 4.6%,p<0.01。
在这项全国范围内的、所有患者纳入的瑞典研究中,SCAD 的总体发病率较低,包括 25%的男性,这一比例高于以往的研究,与非 SCAD MI 相比,SCAD 患者更年轻,心血管风险负担更低,但死亡率和发病率较高,更常进行急性冠状动脉再血管化。